Home / Investor relations / Governance

We apply all the main and supporting principles of good corporate governance in the UK Corporate Governance Code (formerly the Combined Code) and related guidance.

Governance documents

Share options for employees

Director's shareholdings

AstraZeneca’s Board and executive committee receive shares in the Company as part of their compensation to help align their interests with those of shareholders. Read more in our Annual Report and Form 20-F Information for 2023. 


AstraZeneca’s independent external auditor is elected each year by the shareholders at the Annual General Meeting.
At present our auditors are PricewaterhouseCooper LLP.
PricewaterhouseCooper LLP
1 Embankment Place

Corporate governance

As a foreign issuer with American Depositary Shares listed on Nasdaq, we must also disclose any significant ways in which our corporate governance practices differ from those followed by US companies under Nasdaq’s corporate governance listing standards.

Information on our corporate governance performance can be found in our Annual Reports.

The Board

We have a highly experienced Board and Senior Executive Team. The Board is responsible for the Group's corporate governance, sets the Group's strategy and policies, has overall responsibility for the oversight of risk and also monitors progress towards meeting its strategic objectives and annual plans. The Board discharges these responsibilities through a programme of meetings that includes a formal, annual strategy review. The Board also assesses whether or not, and to what extent, its obligations to the Company's shareholders and other stakeholders are understood and met. This includes regular reviews of the Group's financial performance and critical business issues.

More information on the principle roles and responsibilities of our Board can be found in the corporate governance section of our latest Annual Report.

The terms and conditions of appointment of Non-Executive Directors are available to view and download here: